Quant Healthcare Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.
NAV: ₹18.37+0.36%
16 Jul 2026
Loading…
| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 95.20% | 95.05% | 88.96% | 99.94% | 99.38% | 96.34% |
| Debt | 6.86% | 5.59% | 5.94% | 6.69% | 16.85% | 19.14% |
| Others (incl. cash) | -2.06% | -0.64% | 5.11% | -6.64% | -16.23% | -15.48% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| HFCL Ltd. | Communication | 19,77,223 | 42.09 | 10.76% | 1.21%↑ |
| Zydus Wellness Ltd. | Consumer Staples | 6,41,730 | 36.93 | 9.44% | 0.71%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 4,46,671 | 35.04 | 8.96% | 0.23%↑ |
| Concord Biotech Ltd. | Healthcare | 2,69,939 | 34.56 | 8.84% | - |
| SMS Pharmaceuticals Ltd. | Healthcare | 7,72,728 | 31.88 | 8.15% | 0.49%↑ |
| Alivus Life Sciences Ltd | Healthcare | 2,46,298 | 28.48 | 7.28% | 0.30%↑ |
| Pfizer Ltd. | Healthcare | 47,954 | 21.29 | 5.44% | -0.48%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 1,29,172 | 20.39 | 5.21% | 0.27%↑ |
| Strides Pharma Science Ltd. | Healthcare | 1,02,255 | 11.18 | 2.86% | 0.23%↑ |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 32,498 | 7.96 | 2.04% | 0.11%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 70,148 | 7.92 | 2.03% | - |
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 75.00% | 66.22% | 61.95% | 76.59% | 75.13% | 72.87% |
| Communication | 10.76% | 9.55% | 7.14% | - | - | - |
| Consumer Staples | 9.44% | 8.74% | 9.27% | 8.38% | 7.05% | 12.52% |
| Insurance | - | 9.12% | 9.25% | 14.36% | 16.65% | - |
| Capital Goods | - | 1.42% | - | - | - | - |
| Financial | - | - | 1.34% | - | - | 4.79% |
| Services | - | - | - | 0.61% | 0.56% | 6.16% |
28.6 / 100
Weighted average Value score is 28.6. This indicates that portfolio is relatively reasonably valued using composite of value measures.
81.1 / 100
Weighted average Price Momentum score is 81.1. This indicates that portfolio has high momentum using composite of momentum measures.
71.0 / 100
Weighted average Quality score is 71.0. This indicates that portfolio has average quality using composite of quality measures.
66.4 / 100
Weighted average QVM score is 66.4. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.